Skip to main content

FDA Approved Magnevist Alleged For Multiple Organ Damages

FDA Approved Magnevist Alleged For Multiple Organ Damages

FDA Approved Magnevist Alleged For Multiple Organ Damages

Introduction

The U.K. Royal College of Radiologists recently updated a 23-page document, which contains the risks linked to the use of gadolinium-based MRI contrast dyes, along with guidance that covers safety, prescribing, consent, identification of patients at increased risk from contrast administration, pregnancy and lactation. Magnevist is one of the eight approved gadolinium-based MRI contrast dyes for use in the United States by the U.S. Food & Drug Administration (FDA).

According to a case filed the U.S. District Court for the Eastern District of Louisiana on April 26, a couple alleged that the dye Magnevist injected before undergoing an MRI scan caused a number of symptoms like confusion, weakness, fatigue, difficult and painful movement, which are commonly referred to as Gadolinium Deposition Disease. The husband also indicated that Gadolinium was deposited in his brain, heart, liver, and kidney.

Dozens of lawsuits are filed in the United States for Gadolinium Deposition Disease alleging the side effects of Magnevist, a gadolinium-based contrast agent (GBCA) used to enhance MRI scans. The plaintiffs claimed that their kidneys were healthy when they underwent MRIs and stated the manufacturers failed to appropriate safety warnings. The manufacturers were required to provide warnings in a Medication Guide, which all patients receiving an MRI contrast dye will be asked to read after the drug safety communication was issued by the FDA In December 2017. The number of Gadolinium retention lawsuits are expected to continue to increase over the coming months and years.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

Valsartan “Wave 2” Bellwether Trial Schedule Set by Court

Categories: Valsartan

As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.

This move comes in anticipation of the possibility that parties may…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!